Congress Poised to Create 15-Member Panel on AIDS

WASHINGTON—A bill calling for the creation of a national advisory panel on AIDS is moving swiftly through Congress. The bill, which passed the House last month and could be taken up as early as this month by the Senate, would authorize the president and Congress to appoint a 15-member panel to make policy recommendations in the areas of AIDS research, testing, treatment and education The bill specifies that at least eight members would be “recognized experts” in the fields

Written byAmy Mcdonald
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON—A bill calling for the creation of a national advisory panel on AIDS is moving swiftly through Congress.

The bill, which passed the House last month and could be taken up as early as this month by the Senate, would authorize the president and Congress to appoint a 15-member panel to make policy recommendations in the areas of AIDS research, testing, treatment and education The bill specifies that at least eight members would be “recognized experts” in the fields of science, medicine, law or ethics. The panel would be required to make preliminary recommendations to Congress within one year, and issue a final report in two years.

The bill received bipartisan support in the House despite objections that President Reagan’s recently appointed commission preempted the need for a congressional panel.

“This will complement the president’s commission,” responded Rep. J. Roy Rowland (D-Ga.), sponsor of the bill. “The two groups will ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies